Lingvay I, Brown-Frandsen K, Colhoun HM et al
Vivid dreams during weight loss are not unique to Retatrutide
has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
470 In this trial, semaglutide benefited patients with heart failure and preserved ejection fraction by intervening with upstream metabolic drivers
In tirzepatide trials, reductions were often larger, with some analyses showing average decreases of 25 to 30% or more at higher doses
doi: 10.1055/s-2007-1003745 173 ThondamSKDaousiCWildingJPHolstJJAmeenGIYangCet al